Abstract
Purpose
We aimed to explore the relationship between the magnetic resonance imaging (MRI) radiomic score (rad-score) and the grades of non-functioning pancreatic neuroendocrine tumors (NF-pNETs) and evaluate the potential of the calculated MRI rad-score to differentiate grade 1 from grade 2/3 NF-pNETs.
Methods
This retrospective study assessed 157 patients with surgically resected, pathologically confirmed NF-pNETs who underwent magnetic resonance scans from November 2012 to December 2019. Radiomic features were extracted from arterial and portal venous MRI. The least absolute shrinkage and selection operator method were used to select the features. Multivariate logistic regression models were used to analyze the association between the MRI rad-score and NF-pNET grades. The MRI rad-score performance was assessed based on its discriminative ability and clinical usefulness.
Results
The MRI rad-score, which consisted of seven selected features, was significantly associated with the NF-pNET grades. Every 1-point increase in the rad-score was associated with a 35% increased risk of grade 2/3 disease. The score also showed high accuracy (area under the curve = 0.775). The best cut-off point for maximal sensitivity and specificity was at 0.41. In the decision curves, when the threshold probability was higher than 0.3, the rad-score used in this study to distinguish grades 1 and 2/3 NF-pNETs offered more benefits than the use of a treat-all-patients or a treat-none scheme.
Conclusions
The MRI rad-score showed a significant association with the grades of NF-pNETs. Thus, it may be used as a valuable non-invasive tool for differential NF-pNET grading.
Similar content being viewed by others
References
Kloppel G, Perren A, Heitz PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014:13-27. https://doi.org/10.1196/annals.1294.002
Jensen RT, Cadiot G, Brandi ML, et al. (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology 95:98-119. https://doi.org/10.1159/000335591
Sorbye H, Strosberg J, Baudin E, et al. (2014) Gastroenteropancreatic high-grade neuroendocrine carcinoma. Cancer 120:2814-2823. https://doi.org/10.1002/cncr.28721
J AM, Masashi F, S KD, et al. (2019) WHO Classification of Tumours of the Digestive System, 5 edn. IARC Press, Lyon, France
Bosman FT CF, Hruban RH, Theise ND (2010) WHO Classification of Tumours of the Digestive System, 4 edn. IARC Press, Lyon, France
Sumiyoshi H, Matsushita A, Nakamura Y, et al. (2014) [Radical resection of a locally advanced pancreatic tail adenosquamous carcinoma treated with S-1 and gemcitabine as neoadjuvant chemotherapy - a case report]. Gan To Kagaku Ryoho 41:669–672.
Inzani F, Petrone G, Rindi G (2018) The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia. Endocrinol Metab Clin North Am 47:463-470. https://doi.org/10.1016/j.ecl.2018.04.008
Milione M, Maisonneuve P, Spada F, et al. (2017) The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories. Neuroendocrinology 104:85-93. https://doi.org/10.1159/000445165
Basturk O, Yang Z, Tang LH, et al. (2015) The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. Am J Surg Pathol 39:683-690. https://doi.org/10.1097/PAS.0000000000000408
Sorbye H, Welin S, Langer SW, et al. (2013) Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol 24:152-160. https://doi.org/10.1093/annonc/mds276
Crippa S, Partelli S, Bassi C, et al. (2016) Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters. Surgery 159:862-871. https://doi.org/10.1016/j.surg.2015.09.012
Fazio N, Spada F, Giovannini M (2013) Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view. Cancer Treat Rev 39:270-274. https://doi.org/10.1016/j.ctrv.2012.06.009
Panzuto F, Boninsegna L, Fazio N, et al. (2011) Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol 29:2372-2377. https://doi.org/10.1200/JCO.2010.33.0688
Yang G, Ji M, Chen J, et al. (2017) Surgery management for sporadic small (</=2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET). Int J Oncol 50:567-574. https://doi.org/10.3892/ijo.2016.3826
Lambin P, Rios-Velazquez E, Leijenaar R, et al. (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48:441-446. https://doi.org/10.1016/j.ejca.2011.11.036
Kumar V, Gu Y, Basu S, et al. (2012) Radiomics: the process and the challenges. Magn Reson Imaging 30:1234-1248. https://doi.org/10.1016/j.mri.2012.06.010
Canellas R, Burk KS, Parakh A, et al. (2018) Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis. AJR Am J Roentgenol 210:341-346. https://doi.org/10.2214/AJR.17.18417
Choi TW, Kim JH, Yu MH, et al. (2018) Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis. Acta Radiol 59:383-392. https://doi.org/10.1177/0284185117725367
Gu D, Hu Y, Ding H, et al. (2019) CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study. Eur Radiol 29:6680-6890. https://doi.org/10.1007/s00330-019-06176-x
Liang W, Yang P, Huang R, et al. (2019) A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Clin Cancer Res 25:584-594. https://doi.org/10.1158/1078-0432.CCR-18-1305
Gao X, Wang X (2019) Deep learning for World Health Organization grades of pancreatic neuroendocrine tumors on contrast-enhanced magnetic resonance images: a preliminary study. Int J Comput Assist Radiol Surg 14:1981-1991. https://doi.org/10.1007/s11548-019-02070-5
De Robertis R, Maris B, Cardobi N, et al. (2018) Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? Eur Radiol 28:2582-2591. https://doi.org/10.1007/s00330-017-5236-7
Watanabe H, Okada M, Kaji Y, et al. (2009) New response evaluation criteria in solid tumours-revised RECIST guideline (version 1.1). Gan To Kagaku Ryoho 36:2495–2501. doi:
Chalkidou A, O'Doherty MJ, Marsden PK (2015) False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review. PloS one 10:e0124165. https://doi.org/10.1371/journal.pone.0124165
Lubner MG, Smith AD, Sandrasegaran K, et al. (2017) CT Texture Analysis: Definitions, Applications, Biologic Correlates, and Challenges. Radiographics 37:1483-1503. https://doi.org/10.1148/rg.2017170056
Campbell F, Verbeke CS (2013) Pathology of the Pancreas: A Practical Approach. Springer-Verlag London, London
Amin MB, Edge S, Greene F, et al. (2017) AJCC Cancer Staging Manual, 8 edn. Springer, New York
Matsubayashi H, Matsui T, Yabuuchi Y, et al. (2016) Endoscopic ultrasonography guided-fine needle aspiration for the diagnosis of solid pancreaticobiliary lesions: Clinical aspects to improve the diagnosis. World J Gastroenterol 22:628-640. https://doi.org/10.3748/wjg.v22.i2.628
Lee YN, Moon JH, Kim HK, et al. (2014) A triple approach for diagnostic assessment of endoscopic ultrasound-guided fine needle aspiration in pancreatic solid masses and lymph nodes. Dig Dis Sci 59:2286-2293. https://doi.org/10.1007/s10620-014-3119-1
Wallace MB, Kennedy T, Durkalski V, et al. (2001) Randomized controlled trial of EUS-guided fine needle aspiration techniques for the detection of malignant lymphadenopathy. Gastrointest Endosc 54:441-447. https://doi.org/10.1067/mge.2001.117764
Yamada S, Fujii T, Suzuki K, et al. (2016) Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography. Pancreas 45:198-203. https://doi.org/10.1097/MPA.0000000000000443
32Kim DW, Kim HJ, Kim KW, et al. (2016) Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients. Eur Radiol 26:1320-1329. https://doi.org/10.1007/s00330-015-3943-5
33Kim DW, Kim HJ, Kim KW, et al. (2015) Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol 25:1375-1383. https://doi.org/10.1007/s00330-014-3532-z
34Toshima F, Inoue D, Komori T, et al. (2017) Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors? Jpn J Radiol 35:242-253. https://doi.org/10.1007/s11604-017-0627-x
35Kulali F, Semiz-Oysu A, Demir M, et al. (2018) Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors. Diagn Interv Imaging 99:301-309. https://doi.org/10.1016/j.diii.2017.10.012
36Kim JH, Eun HW, Kim YJ, et al. (2013) Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade. Abdom Imaging 38:1106-1114. https://doi.org/10.1007/s00261-013-0011-y
37De Robertis R, Cingarlini S, Tinazzi Martini P, et al. (2017) Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage. World J Gastroenterol 23:275-285. https://doi.org/10.3748/wjg.v23.i2.275
38Moons KG, Altman DG, Reitsma JB, et al. (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162:W1-73. https://doi.org/10.7326/M14-0698
39Vickers AJ, Elkin EB (2006) Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 26:565-574. https://doi.org/10.1177/0272989X06295361
Acknowledgements
Huiying Medical Technology (Beijing) Co., Ltd, Beijing, China
Funding
This work was supported in part by National Science Foundation for Scientists of China (81871352), National Science Foundation for Young Scientists of China (81701689, 81601468), 63-class General Financial Grant from the China Postdoctoral Science Foundation (2018M633714), Key Junior College of National Clinical of China, Shanghai Technology Innovation Project 2017 on Clinical Medicine (17411952200), and Project of Precision Medical Transformation Application of NMMU (2017JZ42).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bian, Y., Li, J., Cao, K. et al. Magnetic resonance imaging radiomic analysis can preoperatively predict G1 and G2/3 grades in patients with NF-pNETs. Abdom Radiol 46, 667–680 (2021). https://doi.org/10.1007/s00261-020-02706-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-020-02706-0